J. Dienstag, Hepatitis B Virus Infection, New England Journal of Medicine, vol.359, issue.14, pp.1486-1500, 2008.
DOI : 10.1056/NEJMra0801644

F. Zoulim and R. Perrillo, Hepatitis B: Reflections on the current approach to antiviral therapy, Journal of Hepatology, vol.48, issue.1, pp.2-19, 2008.
DOI : 10.1016/j.jhep.2008.01.011

F. Zoulim, D. Durantel, and P. Deny, Management and prevention of drug resistance in chronic hepatitis B, Liver International, vol.40, issue.1, pp.108-115, 2009.
DOI : 10.1111/j.1478-3231.2008.01939.x

P. Gripon, C. Diot, N. Theze, I. Fourel, O. Loreal et al., Hepatitis 12 B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide, J Virol, vol.13, issue.62, pp.4136-4143, 1988.

E. Walter, R. Keist, B. Niederost, I. Pult, and H. Blum, Hepatitis B virus infection of tupaia 15 hepatocytes in vitro and in vivo, Hepatology, vol.24, pp.1-5, 1996.

C. &-guguen-guillouzo and C. , Infection of a human hepatoma cell line by hepatitis B virus, Proc Natl, vol.18

V. Thibault, C. Aubron-olivier, H. Agut, and C. Katlama, Primary infection with a lamivudine-resistant hepatitis B virus, AIDS, vol.16, issue.1, pp.131-133, 2002.
DOI : 10.1097/00002030-200201040-00020

D. Kremsdorf and N. Brezillon, New animal models for hepatitis C viral infection and pathogenesis studies, World Journal of Gastroenterology, vol.13, issue.17, pp.2427-2435, 2007.
DOI : 10.3748/wjg.v13.i17.2427

P. Meuleman and G. Leroux-roels, The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCV, Antiviral Research, vol.80, issue.3, pp.231-238, 2008.
DOI : 10.1016/j.antiviral.2008.07.006

M. Sugiyama, Y. Tanaka, F. Kurbanov, I. Maruyama, T. Shimada et al., Direct Cytopathic Effects of Particular Hepatitis B Virus Genotypes in Severe Combined Immunodeficiency Transgenic With Urokinase-Type Plasminogen Activator Mouse With Human Hepatocytes, Gastroenterology, vol.136, issue.2, pp.652-662, 2009.
DOI : 10.1053/j.gastro.2008.10.048

L. Fischer, J. Pollok, B. Erbes, S. Seitz, and S. Urban, Prevention of hepatitis B virus infection in vivo 34 by entry inhibitors derived from the large envelope protein, Nat Biotechnol, vol.26, issue.35, pp.335-341, 2008.

A. Gocht, J. Kock, H. Blum, F. Von-weizsacker, and J. Petersen, Chronic infection with hepatitis B 37 viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes, J, vol.38

Y. Fujimoto, H. Ochi, K. Chayama, C. Tateno, and K. Yoshizato, Infection of human hepatocyte chimeric 1 mouse with genetically engineered hepatitis B virus, Hepatology, vol.42, pp.1046-1054, 2005.